IceCure Medical (ICCM) Competitors $1.01 -0.01 (-0.98%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$1.01 +0.00 (+0.50%) As of 08/1/2025 07:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ICCM vs. ZIMV, SMTI, BWAY, TCMD, CV, CVRX, MGRM, SKIN, SGHT, and TLSIShould you be buying IceCure Medical stock or one of its competitors? The main competitors of IceCure Medical include ZimVie (ZIMV), Sanara MedTech (SMTI), Brainsway (BWAY), Tactile Systems Technology (TCMD), CapsoVision (CV), CVRx (CVRX), Monogram Orthopaedics (MGRM), Beauty Health (SKIN), Sight Sciences (SGHT), and TriSalus Life Sciences (TLSI). These companies are all part of the "medical equipment" industry. IceCure Medical vs. Its Competitors ZimVie Sanara MedTech Brainsway Tactile Systems Technology CapsoVision CVRx Monogram Orthopaedics Beauty Health Sight Sciences TriSalus Life Sciences IceCure Medical (NASDAQ:ICCM) and ZimVie (NASDAQ:ZIMV) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, media sentiment, institutional ownership, earnings, valuation and profitability. Does the media refer more to ICCM or ZIMV? In the previous week, ZimVie had 7 more articles in the media than IceCure Medical. MarketBeat recorded 9 mentions for ZimVie and 2 mentions for IceCure Medical. ZimVie's average media sentiment score of 0.49 beat IceCure Medical's score of 0.00 indicating that ZimVie is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IceCure Medical 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral ZimVie 3 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility & risk, ICCM or ZIMV? IceCure Medical has a beta of 0.31, meaning that its stock price is 69% less volatile than the S&P 500. Comparatively, ZimVie has a beta of 2.19, meaning that its stock price is 119% more volatile than the S&P 500. Is ICCM or ZIMV more profitable? ZimVie has a net margin of -4.39% compared to IceCure Medical's net margin of -467.37%. ZimVie's return on equity of 6.37% beat IceCure Medical's return on equity.Company Net Margins Return on Equity Return on Assets IceCure Medical-467.37% -182.26% -112.65% ZimVie -4.39%6.37%3.34% Which has preferable earnings and valuation, ICCM or ZIMV? IceCure Medical has higher earnings, but lower revenue than ZimVie. ZimVie is trading at a lower price-to-earnings ratio than IceCure Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIceCure Medical$3.27M18.11-$15.32M-$0.28-3.61ZimVie$449.75M1.16-$25.83M-$0.70-26.80 Do insiders & institutionals hold more shares of ICCM or ZIMV? 0.6% of IceCure Medical shares are held by institutional investors. Comparatively, 95.6% of ZimVie shares are held by institutional investors. 2.4% of IceCure Medical shares are held by insiders. Comparatively, 3.0% of ZimVie shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Do analysts recommend ICCM or ZIMV? IceCure Medical presently has a consensus target price of $2.50, suggesting a potential upside of 147.52%. ZimVie has a consensus target price of $17.75, suggesting a potential downside of 5.38%. Given IceCure Medical's stronger consensus rating and higher probable upside, equities research analysts clearly believe IceCure Medical is more favorable than ZimVie.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IceCure Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50ZimVie 0 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryZimVie beats IceCure Medical on 9 of the 17 factors compared between the two stocks. Get IceCure Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for ICCM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ICCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ICCM vs. The Competition Export to ExcelMetricIceCure MedicalMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$59.87M$7.18B$5.48B$9.53BDividend YieldN/A2.90%4.73%4.09%P/E Ratio-3.6164.1328.8923.83Price / Sales18.1133.83371.1466.13Price / CashN/A25.7735.4557.96Price / Book8.428.618.265.54Net Income-$15.32M$239.96M$3.25B$259.28M7 Day Performance-5.61%-5.48%-3.73%-4.67%1 Month PerformanceN/A-3.73%4.28%4.37%1 Year Performance53.52%18.27%25.85%17.90% IceCure Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ICCMIceCure Medical2.037 of 5 stars$1.01-1.0%$2.50+147.5%+52.3%$59.87M$3.27M-3.6160ZIMVZimVie0.9358 of 5 stars$18.76+122.3%$16.33-12.9%-8.0%$235.03M$449.75M-26.421,770News CoverageEarnings ReportUpcoming EarningsAnalyst DowngradeHigh Trading VolumeSMTISanara MedTech1.5836 of 5 stars$26.28-0.1%$49.50+88.4%-19.4%$233.84M$86.67M-19.6160BWAYBrainsway3.2518 of 5 stars$12.09flat$14.25+17.9%+64.6%$228.47M$41.02M60.45120News CoveragePositive NewsUpcoming EarningsGap UpTCMDTactile Systems Technology3.4901 of 5 stars$9.66+1.5%$16.00+65.6%-22.4%$221.32M$293.16M14.641,037News CoverageUpcoming EarningsCVCapsoVisionN/A$4.45-2.2%N/AN/A$210.87MN/A0.0090News CoveragePositive NewsAnalyst RevisionCVRXCVRx2.6716 of 5 stars$8.29+3.6%$14.50+74.9%-8.9%$208.58M$51.29M-3.80160Positive NewsUpcoming EarningsMGRMMonogram Orthopaedics1.323 of 5 stars$5.69+0.4%$5.40-5.1%+128.4%$202.35M$370K-12.6428News CoveragePositive NewsSKINBeauty Health1.495 of 5 stars$1.66+4.4%$1.42-14.7%-10.0%$200.33M$334.30M-4.051,030Trending NewsUpcoming EarningsAnalyst ForecastSGHTSight Sciences2.0911 of 5 stars$3.43-2.0%$3.93+14.7%-55.9%$180.93M$79.87M-3.50210TLSITriSalus Life Sciences2.2037 of 5 stars$4.57-0.7%$10.75+135.2%-27.9%$174.06M$29.43M-4.08106 Related Companies and Tools Related Companies ZIMV Alternatives SMTI Alternatives BWAY Alternatives TCMD Alternatives CV Alternatives CVRX Alternatives MGRM Alternatives SKIN Alternatives SGHT Alternatives TLSI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ICCM) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredDon’t Touch Tesla Stock Without Reading This FirstJeff Brown says he wouldn’t touch Tesla stock right now—and the reason might shock you. A 40-year Wall Stre...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IceCure Medical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share IceCure Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
